Tag Archives: cancer
Scientists have discovered a potential new target for the treatment of leukemia that potentially could augment the activity of BET inhibitors, drugs currently in clinical trials. These therapies act on histones, DNA’s packaging proteins, to reset gene regulatory programs that go awry in cancer.
Biophysicist Gregory Alushin studies how cells use their structural filaments to respond to forces generated as the cells move about, or by movements in the surrounding tissue. He will relocate his lab to Rockefeller early next year. More »
A new cancer treatment called CD40 antibody has yielded disappointing results when tested in clinical trials, failing to mobilize patients’ immune system against tumors the way it was expected to. But a recent study offers clues about how this experimental drug might be optimized to fulfill its potential. More »
Will We Find a Cure for Cancer and Alzheimer’s Anytime Soon? “Science is on the march in the heart of New York City. With five Nobel Laureates on its faculty, Rockefeller University scientists are working to unlock the mysteries … More »
Sometimes, in cancer cells, a part of a chromosome looks like it has been pulverized, then put back together incorrectly, leading to multiple mutations. New research from The Rockefeller University describes the cellular events leading to this molecular explosion, which serves as a precursor to cancer. More »
Researchers found they could disrupt STAT3’s ability to act as a transcription factor and so contribute to the proliferation of cancerous cells, by altering a particular part of the protein. This accomplishment suggests a basis for new, targeted approaches to fighting cancer. More »
In some cases of acute myeloid leukemia, a mutant protein is known to cause dramatic changes in gene expression. Now researchers have identified a second protein with similar function that plays an even broader role in the disease. More »
New research shows that a family of experimental cancer drugs can induce neurological changes in mice. The findings underscore the need for more research to determine whether these compounds can enter the brain, where they potentially might cause side effects such as memory loss. More »
New research reveals how cells sort out the RNA molecules destined to become gene-regulating microRNAs by tagging them. Because microRNAs help control processes throughout the body, this discovery has wide-ranging implications for development, health and disease, including cancer.
How spread of breast cancer could be stopped “Professor Sohail Tavazoie, who led the research, said: ‘If we learn more about how this regulation works, we may in the future be able to generate drugs that prevent this protein from … More »
Schramek, one of just two individuals receiving the annual award, is being recognized for his proposal of a project that used sequence-based personalized medicine to treat the most devastating features of cancer. The award comes with a $50,000 prize and a $5,000 donation to support seminars at Rockefeller. More »
In the race for better treatments and possible cures, rare diseases are often left behind. In a collaboration of researchers at The Rockefeller University, Memorial Sloan Kettering Cancer Center and the New York Genome Center, an unusual mutation has been found that is strongly linked to one such disease: a rare liver cancer that affects teens and young adults. More »
The technique, created by scientists in Rockefeller’s Laboratory of Mammalian Cell Biology and Development, attaches short pieces of RNA to highly concentrated viruses and uses ultrasound to inject the viruses into mouse embryos. It takes a fraction of the resources and much less time than using knockout mice to conduct genetic screens, and can assess about 300 genes in a single mouse in as little as five weeks. More »
A detailed analysis of a large panel of so-called ALT cell lines shows that they frequently undergo chromosomal changes and are impaired in their ability to detect and repair damage in their DNA. The work suggests a mechanism by which 10 to 15 percent of human cancers develop. More »